What is the Role of Genomic Biomarkers in Treatment Decisions?
Genomic biomarkers help in tailoring treatment plans for individual patients. For instance, patients with EGFR mutations in lung cancer are often treated with EGFR inhibitors like erlotinib, while those with KRAS mutations may not benefit from these drugs. This targeted approach maximizes treatment efficacy and minimizes unnecessary side effects.
